nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice
|
Shott, Joseph P. |
|
2008 |
26 |
Supplement 5 |
p. 2818-2823 6 p. |
artikel |
2 |
Age for HPV vaccination
|
Harper, Diane M. |
|
2008 |
26 |
Supplement 5 |
p. A7-A11 nvt p. |
artikel |
3 |
Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004
|
Sebastian, R. |
|
2008 |
26 |
Supplement 5 |
p. 1397-1403 7 p. |
artikel |
4 |
Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease
|
Pannaraj, Pia S. |
|
2008 |
26 |
Supplement 5 |
p. 502-508 7 p. |
artikel |
5 |
An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals
|
Hewetson, John F. |
|
2008 |
26 |
Supplement 5 |
p. 4262-4266 5 p. |
artikel |
6 |
A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5′UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice
|
Yang, Bin |
|
2008 |
26 |
Supplement 5 |
p. 5477-5483 7 p. |
artikel |
7 |
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
|
Malkin, Elissa |
|
2008 |
26 |
Supplement 5 |
p. 6864-6873 10 p. |
artikel |
8 |
A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs
|
Yuan, Ziguo |
|
2008 |
26 |
Supplement 5 |
p. 1314-1321 8 p. |
artikel |
9 |
Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings
|
Manissero, Davide |
|
2008 |
26 |
Supplement 5 |
p. 2253-2259 7 p. |
artikel |
10 |
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results
|
Dhiman, Neelam |
|
2008 |
26 |
Supplement 5 |
p. 1731-1736 6 p. |
artikel |
11 |
A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques
|
Itoh, Yasushi |
|
2008 |
26 |
Supplement 5 |
p. 562-572 11 p. |
artikel |
12 |
Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination
|
McKinley, Enid T. |
|
2008 |
26 |
Supplement 5 |
p. 1274-1284 11 p. |
artikel |
13 |
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
|
Sohn, Young Mo |
|
2008 |
26 |
Supplement 5 |
p. 1638-1643 6 p. |
artikel |
14 |
Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: Effects of temperature on protection and gene expression
|
Raida, M.K. |
|
2008 |
26 |
Supplement 5 |
p. 1050-1062 13 p. |
artikel |
15 |
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects
|
Tseng, Chih Wen |
|
2008 |
26 |
Supplement 5 |
p. 4314-4319 6 p. |
artikel |
16 |
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines
|
Wyatt, Linda S. |
|
2008 |
26 |
Supplement 5 |
p. 486-493 8 p. |
artikel |
17 |
Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia
|
Liu, Wei |
|
2008 |
26 |
Supplement 5 |
p. 4456-4460 5 p. |
artikel |
18 |
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
|
Ansaldi, Filippo |
|
2008 |
26 |
Supplement 5 |
p. 1525-1529 5 p. |
artikel |
19 |
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine
|
Gomi, Yasuyuki |
|
2008 |
26 |
Supplement 5 |
p. 5627-5632 6 p. |
artikel |
20 |
Editorial Board
|
|
|
2008 |
26 |
Supplement 5 |
p. CO2- 1 p. |
artikel |
21 |
Editorial Board
|
|
|
2008 |
26 |
Supplement 5 |
p. CO2- 1 p. |
artikel |
22 |
Editorial Board/Aims and Scope
|
|
|
2008 |
26 |
Supplement 5 |
p. CO2- 1 p. |
artikel |
23 |
Editorial Board/Aims and Scope
|
|
|
2008 |
26 |
Supplement 5 |
p. CO2- 1 p. |
artikel |
24 |
Editorial Board/Aims and Scope
|
|
|
2008 |
26 |
Supplement 5 |
p. CO2- 1 p. |
artikel |
25 |
Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation
|
Shinjoh, Masayoshi |
|
2008 |
26 |
Supplement 5 |
p. 6859-6863 5 p. |
artikel |
26 |
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway
|
Vestrheim, Didrik F. |
|
2008 |
26 |
Supplement 5 |
p. 3277-3281 5 p. |
artikel |
27 |
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
|
Kalies, Helen |
|
2008 |
26 |
Supplement 5 |
p. 2545-2552 8 p. |
artikel |
28 |
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990–2006
|
Chang, Soju |
|
2008 |
26 |
Supplement 5 |
p. 2428-2432 5 p. |
artikel |
29 |
Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005
|
Harboe, Zitta B. |
|
2008 |
26 |
Supplement 5 |
p. 3765-3771 7 p. |
artikel |
30 |
Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys
|
Nigatu, Wondatir |
|
2008 |
26 |
Supplement 5 |
p. 4769-4774 6 p. |
artikel |
31 |
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
|
von Teichman, Beate F. |
|
2008 |
26 |
Supplement 5 |
p. 5014-5021 8 p. |
artikel |
32 |
Evaluation of widely consumed botanicals as immunological adjuvants
|
Ragupathi, Govind |
|
2008 |
26 |
Supplement 5 |
p. 4860-4865 6 p. |
artikel |
33 |
Experimental use of the attenuated Ehrlichia ruminantium (Welgevonden) vaccine in Merino sheep and Angora goats
|
Zweygarth, Erich |
|
2008 |
26 |
Supplement 5 |
p. G34-G39 nvt p. |
artikel |
34 |
Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy
|
Kim, Jane J. |
|
2008 |
26 |
Supplement 5 |
p. 4015-4024 10 p. |
artikel |
35 |
Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells
|
Harenberg, Anke |
|
2008 |
26 |
Supplement 5 |
p. 5004-5013 10 p. |
artikel |
36 |
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
|
Goldie, Sue J. |
|
2008 |
26 |
Supplement 5 |
p. 4080-4093 14 p. |
artikel |
37 |
Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus
|
Vashisht, Kapil |
|
2008 |
26 |
Supplement 5 |
p. 4747-4753 7 p. |
artikel |
38 |
Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis
|
Low, Nicola |
|
2008 |
26 |
Supplement 5 |
p. 383-398 16 p. |
artikel |
39 |
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial
|
Jiang, Wei-Ping |
|
2008 |
26 |
Supplement 5 |
p. 2297-2301 5 p. |
artikel |
40 |
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
|
Saaka, M. |
|
2008 |
26 |
Supplement 5 |
p. 3719-3726 8 p. |
artikel |
41 |
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants
|
Olivier, C. |
|
2008 |
26 |
Supplement 5 |
p. 3142-3152 11 p. |
artikel |
42 |
Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction
|
Domínguez, A. |
|
2008 |
26 |
Supplement 5 |
p. 1737-1741 5 p. |
artikel |
43 |
Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis
|
Morales, Julio |
|
2008 |
26 |
Supplement 5 |
p. 2899-2905 7 p. |
artikel |
44 |
Influence of the Ixodes ricinus tick blood-feeding on the antigen-specific antibody response in vivo
|
Menten-Dedoyart, C. |
|
2008 |
26 |
Supplement 5 |
p. 6956-6964 9 p. |
artikel |
45 |
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses
|
Russell, Colin A. |
|
2008 |
26 |
Supplement 5 |
p. D31-D34 nvt p. |
artikel |
46 |
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
|
Andrus, Jon Kim |
|
2008 |
26 |
Supplement 5 |
p. K87-K92 nvt p. |
artikel |
47 |
Invasive Pneumococcal disease in Singapore children
|
Chong, Chia-Yin |
|
2008 |
26 |
Supplement 5 |
p. 3427-3431 5 p. |
artikel |
48 |
In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets
|
Linghua, Zhang |
|
2008 |
26 |
Supplement 5 |
p. 224-233 10 p. |
artikel |
49 |
Issues with reducing the rotavirus-associated mortality by vaccination in developing countries
|
Naghipour, Mohammadreza |
|
2008 |
26 |
Supplement 5 |
p. 3236-3241 6 p. |
artikel |
50 |
Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age
|
Poovorawan, Yong |
|
2008 |
26 |
Supplement 5 |
p. 1535-1540 6 p. |
artikel |
51 |
Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates
|
Jafarzadeh, A. |
|
2008 |
26 |
Supplement 5 |
p. 269-276 8 p. |
artikel |
52 |
Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean
|
Goldie, Sue J. |
|
2008 |
26 |
Supplement 5 |
p. L59-L72 nvt p. |
artikel |
53 |
Mathematical Models of Cervical Cancer Prevention in the Asia Pacific Region
|
Goldie, Sue J. |
|
2008 |
26 |
Supplement 5 |
p. M17-M29 nvt p. |
artikel |
54 |
Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine
|
Arrode, Geraldine |
|
2008 |
26 |
Supplement 5 |
p. 3795-3804 10 p. |
artikel |
55 |
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin
|
Bargieri, Daniel Y. |
|
2008 |
26 |
Supplement 5 |
p. 6132-6142 11 p. |
artikel |
56 |
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
|
Taylor, Claribel P. |
|
2008 |
26 |
Supplement 5 |
p. 3404-3409 6 p. |
artikel |
57 |
Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C
|
Batdelger, Dendev |
|
2008 |
26 |
Supplement 5 |
p. 2733-2737 5 p. |
artikel |
58 |
Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies
|
Zhang, Shoufeng |
|
2008 |
26 |
Supplement 5 |
p. 345-350 6 p. |
artikel |
59 |
Parent-collected respiratory specimens—A novel method for respiratory virus and vaccine efficacy research
|
Lambert, Stephen B. |
|
2008 |
26 |
Supplement 5 |
p. 1826-1831 6 p. |
artikel |
60 |
Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
|
Istrate, Claudia |
|
2008 |
26 |
Supplement 5 |
p. 4594-4601 8 p. |
artikel |
61 |
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Kester, Kent E. |
|
2008 |
26 |
Supplement 5 |
p. 2191-2202 12 p. |
artikel |
62 |
Plant-expressed HA as a seasonal influenza vaccine candidate
|
Shoji, Yoko |
|
2008 |
26 |
Supplement 5 |
p. 2930-2934 5 p. |
artikel |
63 |
Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination
|
Helson, Rebecca |
|
2008 |
26 |
Supplement 5 |
p. 753-761 9 p. |
artikel |
64 |
Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production
|
Elias, Daniel |
|
2008 |
26 |
Supplement 5 |
p. 3897-3902 6 p. |
artikel |
65 |
Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs
|
Manickam, R. |
|
2008 |
26 |
Supplement 5 |
p. 6564-6568 5 p. |
artikel |
66 |
Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis
|
Katoch, K. |
|
2008 |
26 |
Supplement 5 |
p. 1228-1234 7 p. |
artikel |
67 |
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data
|
Bailleux, F. |
|
2008 |
26 |
Supplement 5 |
p. 3903-3908 6 p. |
artikel |
68 |
Prediction of pertussis vaccine efficacy using a correlates of protection model
|
Kohberger, Robert C. |
|
2008 |
26 |
Supplement 5 |
p. 3516-3521 6 p. |
artikel |
69 |
Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease
|
Lu, Zengjun |
|
2008 |
26 |
Supplement 5 |
p. G48-G53 nvt p. |
artikel |
70 |
Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle
|
Chang, Byoung Sun |
|
2008 |
26 |
Supplement 5 |
p. 2081-2091 11 p. |
artikel |
71 |
Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser)
|
Jarvi, Susan I. |
|
2008 |
26 |
Supplement 5 |
p. 5338-5344 7 p. |
artikel |
72 |
Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus
|
Chen, Zhenhai |
|
2008 |
26 |
Supplement 5 |
p. 573-580 8 p. |
artikel |
73 |
Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein
|
Fernandes, Ana Paula |
|
2008 |
26 |
Supplement 5 |
p. 5888-5895 8 p. |
artikel |
74 |
Protective immunity with an E1 multivalent epitope DNA vaccine against cottontail rabbit papillomavirus (CRPV) infection in an HLA-A2.1 transgenic rabbit model
|
Hu, Jiafen |
|
2008 |
26 |
Supplement 5 |
p. 809-816 8 p. |
artikel |
75 |
Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands
|
David, Silke |
|
2008 |
26 |
Supplement 5 |
p. 5883-5887 5 p. |
artikel |
76 |
Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children
|
Esteghamati, Abdoulreza |
|
2008 |
26 |
Supplement 5 |
p. 5058-5061 4 p. |
artikel |
77 |
Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
|
Belshe, Robert B. |
|
2008 |
26 |
Supplement 5 |
p. D10-D16 nvt p. |
artikel |
78 |
Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age
|
Pietrzyk, Jacek J. |
|
2008 |
26 |
Supplement 5 |
p. 5296-5303 8 p. |
artikel |
79 |
Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants
|
Li, Rong Cheng |
|
2008 |
26 |
Supplement 5 |
p. 2260-2269 10 p. |
artikel |
80 |
Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses
|
Sigurdardottir, Sigurveig Th. |
|
2008 |
26 |
Supplement 5 |
p. 4178-4186 9 p. |
artikel |
81 |
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China
|
Zhu, Feng Cai |
|
2008 |
26 |
Supplement 5 |
p. 4579-4584 6 p. |
artikel |
82 |
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines
|
Prymula, Roman |
|
2008 |
26 |
Supplement 5 |
p. 4563-4570 8 p. |
artikel |
83 |
Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine
|
Silva, Ana Carina |
|
2008 |
26 |
Supplement 5 |
p. 3305-3311 7 p. |
artikel |
84 |
Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes
|
Lei, Liancheng |
|
2008 |
26 |
Supplement 5 |
p. 6274-6280 7 p. |
artikel |
85 |
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
|
Block, Stan L. |
|
2008 |
26 |
Supplement 5 |
p. 4940-4946 7 p. |
artikel |
86 |
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
|
Levin, Myron J. |
|
2008 |
26 |
Supplement 5 |
p. 4210-4217 8 p. |
artikel |
87 |
Sudden deaths following influenza vaccination: Can this be expected?
|
van der Sande, M.A.B. |
|
2008 |
26 |
Supplement 5 |
p. 379-382 4 p. |
artikel |
88 |
The antifertility effects of DNA vaccine-induced immune responses against uroguanylin
|
Sun, Jing |
|
2008 |
26 |
Supplement 5 |
p. 3696-3704 9 p. |
artikel |
89 |
The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice
|
Sivaprakasam, V. |
|
2008 |
26 |
Supplement 5 |
p. 3772-3777 6 p. |
artikel |
90 |
The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis
|
Araujo, Zaida |
|
2008 |
26 |
Supplement 5 |
p. 5575-5581 7 p. |
artikel |
91 |
The measles campaign in West and Central Africa: Remembering the future
|
De Groot, Annie |
|
2008 |
26 |
Supplement 5 |
p. 3783-3786 4 p. |
artikel |
92 |
Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: Proof of principle in two strains of rat
|
Stathopoulos, Apostolos |
|
2008 |
26 |
Supplement 5 |
p. 1764-1772 9 p. |
artikel |
93 |
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
|
But, David Yiu-Kuen |
|
2008 |
26 |
Supplement 5 |
p. 6587-6591 5 p. |
artikel |
94 |
Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands
|
Meerveld-Eggink, A. |
|
2008 |
26 |
Supplement 5 |
p. 6975-6979 5 p. |
artikel |
95 |
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
|
Vandepapelière, Pierre |
|
2008 |
26 |
Supplement 5 |
p. 1375-1386 12 p. |
artikel |